One FTSE 100 stock I’d buy over British American Tobacco plc

This defensive play makes a viable alternative to British American Tobacco plc (LON: BATS).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Half-year results from Bunzl (LSE: BNZL) today are predictably good in an outcome that we’ve become used to over recent years. Revenue at constant currency rates is up 7% compared to a year ago and adjusted earnings per share rose 7% too.

Boring but steady

You won’t get over-excited by the firm’s business. The FTSE 100 distribution and outsourcing service company supplies a range of non-food products to several market sectors – stuff that keeps businesses and organisations in multiple sectors ticking over with an easy supply of essentials, such as food packaging, grocery, films, labels, gloves, bandages, safety consumables, and products for cleaning and hygiene.

Dull, dull, dull, but boring and steady is good, because the shares are around 370% higher than they were eight years ago, and the dividend has inflated by more than 60% over the past five years. The directors celebrated the current period of success by slapping another 8% on the interim dividend, which continues an impressive 24-year record of dividend growth.

Around 3.7% of the advance in revenue during the period came from organic growth but the company also announced 11 acquisitions in the first half of the year, which continues a long-running acquisition programme that accelerated this year. Chief executive Frank van Zant is pleased about that, saying in the report that the acquisition activity continues to be an important part of our growth strategy.”

Well-balanced growth

The firm’s expansion seems well-balanced with cash flow from operations sticking close to the levels of operating profit achieved over the past five years. That gives me confidence that dividend growth is well-supported. City analysts following the firm expect earnings to put on 6% this year and 6% during 2018, which means forward earnings cover the anticipated dividend payout for 2018 a solid-looking two-and-a-half times.

Bunzl earns around 52% of operating profit from North America, 26% from continental Europe, 13% from the UK and Ireland and 9% from the rest of the world, making the US its most important market. So, if you are nervous that the Brexit process might affect companies relying on the UK for their business, a firm like Bunzl could be for you. The one slight negative is that the company’s attractions have pushed up the valuation. At today’s share price of 2,311p, the forward price-to-earnings (P/E) ratio for 2018 runs at a little over 19.  

Sector rotation?

Despite the high-looking rating, I think Bunzl leaves a better taste in the mouth than British American Tobacco (LSE: BATS) and its business has attractive defensive characteristics without needing to deal in tobacco. The breaking of the news this summer that the Food and Drug Administration (FDA) in the US plans to reduce nicotine in cigarettes to non-addictive levels seems to have kicked off the recent plunge in tobacco stocks. But I’ve wondered for a long time how far the rally could go and now fear that this could be the beginning of a rotation out of the sector, which seems long overdue.

Today’s 4,761p share price puts BATS on a forward P/E rating lower than Bunzl’s at just over 15, but I’m not tempted and would rather take my chances with Bunzl.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes

More on Investing Articles

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »

Investing Articles

The Meta share price falls 10% on weak Q2 guidance — should investors consider buying?

The Meta Platforms' share price is down 10% after the company reported Q1 earnings per share growth of 117%. Does…

Read more »